Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma

Pediatric Blood and Cancer

Volumn 49, Issue 3, 2007, Pages 256-260

  Chantada, Guillermo L ^a   Dunkel, Ira J ^b   Antoneli, Celia B G ^c   De Dávila, María T G ^a   Arias, Victor ^d   Beaverson, Katherine ^b   Fandiño, Adriana C ^c   Chojniak, Martha ^b   Abramson, David H ^b  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chemoreduction; Pathology; Retinoblastoma

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; TENIPOSIDE; THIOTEPA; TOPOTECAN; VINCRISTINE;

ADOLESCENT; ANTERIOR EYE SEGMENT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CHILD; CHOROID; DRUG DOSE REGIMEN; DRUG TREATMENT FAILURE; ENUCLEATION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OPTIC NERVE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RETINOBLASTOMA; RISK FACTOR; SCLERA; STEM CELL TRANSPLANTATION; SUBARACHNOID SPACE; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; EYE ENUCLEATION; FEMALE; HUMANS; INFANT; MALE; NEOPLASM INVASIVENESS; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 34547774598     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21067     Document Type: Article

References (17)

1. Abramson DH, Schefler AC. Update on retinoblastoma. Retina 2004;24:828-848.
2. Fontanesi J, Pratt CB, Kun LE, et al. Treatment outcome and dose-response relationship in infants younger than 1 year treated for retinoblastoma with primary irradiation. Med Pediatr Oncol 1996; 26:297-304.
3. Abramson DH, Beaverson KL, Chang ST, et al. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma. Arch Ophthalmol 2004;122:1316-1323.
4. Kingston JE, Hungerford JL, Madreperla SA, et al. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 1996;114:1339-1343.
5. Lee V, Hungerford JL, Bunce C, et al. Globe conserving treatment of the only eye in bilateral retinoblastoma. Br J Ophthalmol 2003; 87:1374-1380.
6. Brichard B, De Bruycker JJ, De Potter P, et al. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Med Pediatr Oncol 2002;38:411-415.
7. Howarth C, Meyer D, Hustu HO, et al. Stage-related combined modality treatment of retinoblastoma. Results of a prospective study. Cancer 1980;45:851-858.
8. Schvartzman E, Chantada G, Fandino A, et al. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol 1996;14:1532-1536.
9. Khelfaoui F, Validire P, Auperin A, et al. Histopathologic risk factors in retinoblastoma: A retrospective study of 172 patients treated in a single institution. Cancer 1996;15;77:1206-1213.
10. Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 2002;120: 923-931.
11. Chantada GL, Dunkel IJ, de Davila MT, et al. Retinoblastoma patients with high risk ocular pathological features: Who needs adjuvant therapy? Br J Ophthalmol 2004;88:1069-1073.
12. Bechrakis N, Bornfeld N, Schuler A, et al. Clinicopathological features of retinoblastoma after primary chemoreduction. Arch Ophthalmol 1998;116:887-893.
13. Demirci H, Eagle R, Shields C, et al. Histopathological findings in eyes with retinoblastoma treated only with chemoreduction. Arch Ophthalmol 2003;121:1125-1131.
14. Shields CL, Shields JA, Baez K, et al. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 1994;73:692-698.
15. Rodriguez-Galindo C, Wilson MW, Haik BG, et al. Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol 2003;21:2019-2025.
16. Dunkel IJ, Aledo A, Kernan NA, et al. Successful treatment of metastatic retinoblastoma. Cancer 2000;89:2117-2121.
17. Chantada GL, de Davila MT, Fandino A, et al. Retinoblastoma with low risk for extraocular relapse. Ophthalmic Genet 1999;20:133-140.